(OP:AIMN)

0.0069 -0.0001 (-1.43%)

Streaming Delayed Price Updated: 10:37 AM EDT, May 22, 2026 Add to My Watchlist

Price and Volume

Volume	800
Open	0.0069
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.0070
Today's Range	0.0050 - 0.0069
52wk Range	0.0050 - 0.3095
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Quiet Restructuring of Healthcare Intelligence: Why the Industry is Moving Toward Verified Professional Networks Over Anonymous AI

May 20, 2026

Via ACCESS Newswire

Inside AimwellBio's Federated Health Intelligence Network: Verified Clinical Intelligence Model Gains Attention Among Physicians

May 18, 2026

Via ACCESS Newswire

Performance

YTD	-87.5%	-87.5%
1 Month	-42.5%	-42.5%
3 Month	-87.5%	-87.5%
6 Month	-87.5%	-87.5%
1 Year	-87.5%	-87.5%

More News

The Doctors Saw It First. Then the Chiropractors Asked. Now AimwellBio is Adding the Four Signals Every Family in America is Quietly Searching For.

May 13, 2026

Via ACCESS Newswire

Aimwell Partners Brand, AimwellBio Announces Expanded FHIN Intelligence Framework, Early Demo Feedback, and New AIMN Development Milestones

May 11, 2026

Via ACCESS Newswire

While You Were in That Meeting, 14 Signals Moved. Your Competitors Saw Them. You Didn’t.

May 06, 2026

Via ACCESS Newswire

AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape

May 04, 2026

Via ACCESS Newswire

AimwellBio Launches Verified Intelligence Layer for Healthcare as AI Hallucination Risk Reaches Clinical Settings

April 27, 2026

Via ACCESS Newswire

Aimwell Bio Expands FHIN Deployment Across U.S. and Australia as Clinical Leaders Move to Replace Unverified AI Hospitalists and Physician Groups Drive Demand for Source-Traceable Intelligence Infrastructure

April 22, 2026

Via ACCESS Newswire

Aimwell Bio Announces "Founding Cohort" of Federated Health Intelligence Network (FHIN); Tackles 38% AI Hallucination Rate in Biopharma

April 20, 2026

Via ACCESS Newswire

AimwellBio Launches the System That Catches What AI Gets Wrong: Before It Reaches Patients, Boards, or Your Portfolio

April 15, 2026

Via ACCESS Newswire

Frequently Asked Questions

Is AIMN publicly traded?

Yes, AIMN is publicly traded.

What exchange does AIMN trade on?

AIMN trades on the OTC Traded

What is the ticker symbol for AIMN?

The ticker symbol for AIMN is AIMN on the OTC Traded

What is the current price of AIMN?

The current price of AIMN is 0.0069

When was AIMN last traded?

The last trade of AIMN was at 05/22/26 10:37 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.